Ausgabe 1/2021
Inhalt (5 Artikel)
Statin Drugs (R. Ceska, Section Editor)
Should We Target Global Risk or Risk Factors?
Lale Tokgozoglu, Duygu Kocyigit
Open Access
Statin Drugs (R. Ceska, Section Editor)
Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα) in the Metabolic Syndrome: Is Pemafibrate Light at the End of the Tunnel?
Jean-Charles Fruchart, Michel P. Hermans, Jamila Fruchart-Najib, Tatsuhiko Kodama
Vascular Biology (H. Pownall, Section Editor)
AIBP, Angiogenesis, Hematopoiesis, and Atherogenesis
Xueting Qiu, Jingmin Luo, Longhou Fang
Open Access
Vascular Biology (H. Pownall, Section Editor)
High HDL-Cholesterol Paradox: SCARB1-LAG3-HDL Axis
Annabelle Rodriguez
Reviews and New Research Implications (S. Virani, Section Editor)
Highlights from Studies Presented at the American Heart Association Scientific Session 2020: Navigating New Roads in Prevention
Aliza Hussain, Mahmoud Al Rifai, Dhruv Mahtta, Jing Liu, Vardhmaan Jain, Salim S. Virani